Aflac Incorporated (NYSE:AFL) Shares Sold by Public Employees Retirement Association of Colorado

Public Employees Retirement Association of Colorado trimmed its stake in shares of Aflac Incorporated (NYSE:AFL) by 2.2% during the 4th quarter, Holdings Channel reports. The fund owned 72,804 shares of the financial services provider’s stock after selling 1,647 shares during the quarter. Public Employees Retirement Association of Colorado’s holdings in Aflac were worth $7,531,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of AFL. Mission Creek Capital Partners Inc. increased its holdings in Aflac by 54.0% in the fourth quarter. Mission Creek Capital Partners Inc. now owns 27,529 shares of the financial services provider’s stock valued at $2,848,000 after buying an additional 9,649 shares in the last quarter. Aquatic Capital Management LLC grew its position in shares of Aflac by 12.9% during the 4th quarter. Aquatic Capital Management LLC now owns 50,474 shares of the financial services provider’s stock valued at $5,221,000 after acquiring an additional 5,774 shares during the period. Virtus ETF Advisers LLC increased its stake in shares of Aflac by 12.2% in the 4th quarter. Virtus ETF Advisers LLC now owns 10,477 shares of the financial services provider’s stock valued at $1,084,000 after purchasing an additional 1,139 shares in the last quarter. Coldstream Capital Management Inc. raised its holdings in Aflac by 2.6% in the 4th quarter. Coldstream Capital Management Inc. now owns 64,586 shares of the financial services provider’s stock worth $6,681,000 after purchasing an additional 1,650 shares during the period. Finally, Adage Capital Partners GP L.L.C. purchased a new position in Aflac during the fourth quarter worth approximately $20,913,000. 67.44% of the stock is currently owned by hedge funds and other institutional investors.

Aflac Stock Up 0.6 %

AFL opened at $108.55 on Tuesday. The stock has a market capitalization of $59.25 billion, a P/E ratio of 11.31, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.08 and a current ratio of 0.10. Aflac Incorporated has a one year low of $80.59 and a one year high of $115.50. The business’s 50-day simple moving average is $107.22 and its 200-day simple moving average is $107.04.

Aflac (NYSE:AFL) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Analysts anticipate that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Buying and Selling at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Charles D. Lake II sold 29,802 shares of the business’s stock in a transaction on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares in the company, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research analysts have recently weighed in on AFL shares. JPMorgan Chase & Co. upped their target price on Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 2nd. UBS Group increased their price objective on shares of Aflac from $109.00 to $114.00 and gave the company a “neutral” rating in a report on Wednesday, April 2nd. Piper Sandler boosted their target price on shares of Aflac from $118.00 to $124.00 and gave the stock an “overweight” rating in a research note on Wednesday, April 2nd. BMO Capital Markets began coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price target on the stock. Finally, Wells Fargo & Company lowered their price objective on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, Aflac has an average rating of “Hold” and a consensus target price of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.